A study to compare the effects of Chandrashoor Churna and Metformin, along with diet and lifestyle changes, in managing irregular menstrual cycles in women with PCOS

Evaluation of Comparative Efficacy of Chandrashoor Churna versus Tablet Metformin with dietary and lifestyle modifications in both groups in the Management of Artavakshaya (Oligomenorrhoea in Polycystic Ovarian Syndrome): A Randomised Control Trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095661

Enrollment

Registered

2025-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Females aged 18 35 years Diagnosed with PCOS based on USG Presenting with symptoms of Oligomenorrhoea Presenting with symptoms of Artavakshaya Scanty menstrual flow Informed consent given

Exclusion criteria

Exclusion criteria: Women with secondary causes of amenorrhea eg hypothyroidism hyperprolactinemia premature ovarian failure Presence of structural abnormalities eg fibroids endometriosis or tubal blockagesKnown cases of Type 1 or Type 2 diabetes mellitus Thyroiddysfunction Hyperprolactinemia Cushings syndrome Women on Hormonal therapy OCPs HRT etc Antidiabetic antiobesity or steroidal drugs in the past 3 months Lactating women or who want to conceive during this period Known allergy or intolerance to Chandrashoor or Metformin History of chronic illnesses affecting reproductive health (e.g renal failure, liver disease) Participation in any other clinical trial within the last 3 months

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Chandrashoor Churna with dietary and lifestyle regimen in the Management of Artavakshaya (Oligomenorrhoea in polycystic ovarian syndrome) Timepoint: 0 week,4 week, 8 week	—

Secondary

Measure	Time frame
To evaluate and compare the improvement in menstrual irregularities, reduction in pain in both groups.Timepoint: 3 months (2 consecutive menstrual cycle ) during study With 3 months (2 consecutive menstrual cycle ) follow up after study	—

Countries

India

Contacts

Public ContactDr Disha Sudhakar Shetty

Mahatma Gandhi Ayurveda College Hospital and Research Centre ,Salod Wardha

drbhagyashrichaudhari@gmail.com9096415920

Outcome results